Beyond its implications in bladder cancer, FAM171B seems to exert substantial immunomodulatory effects in digestive tumors, including colon adenocarcinoma, liver hepatocellular carcinoma, and pancreatic adenocarcinoma. The gene discussed is FAM171B; the disease is urinary bladder cancer.